Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van Lint

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Annual Review of Virology|September 29, 2021
The Current Status of Latency Reversing Agents for HIV-1 RemissionAnthony Rodari, Gilles Darcis, Carine M Van Lint
Bulletin De La Societe Belge D'Ophtalmologie|June 8, 2007
Iatrogenic ocular vascular occlusions: case reportsM van Lint, C De Cock, Ph Kestelyn, et al.
Orbit (Amsterdam, Netherlands)|May 3, 2014
Subconjunctival epidermoid cysts in Gorlin-Goltz syndromeS De Craene, A Batteauw, M Van Lint, et al.
Journal of Clinical Immunology|July 1, 1997
The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipidsW M Vuist, I N Van Schaik, M Van Lint, et al.
Journal of Neuroimmunology|September 1, 1990
On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathyP A van Doorn, F Rossi, A Brand, et al.
Journal of Lipid Research|March 15, 2002
Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disordersS Ferdinandusse, H Rusch, A E M van Lint, et al.
Immunological Reviews|August 1, 1989
Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: spontaneous and therapeuticI Lundkvist, P A van Doorn, M Vermeulen, et al.
Bone Marrow Transplantation|June 1, 1996
Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late EffectsA Tichelli, T Duell, M Weiss, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 9, 2019
Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significanceF H M van Lint, O R F Mook, M Alders, et al.
Molecular Genetics and Metabolism|July 12, 2003
Analysis of very long-chain fatty acids using electrospray ionization mass spectrometryFredoen Valianpour, Jacqueline J M Selhorst, Lia E M van Lint, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Annual Review of Virology|September 29, 2021
The Current Status of Latency Reversing Agents for HIV-1 RemissionAnthony Rodari, Gilles Darcis, Carine M Van Lint
Bulletin De La Societe Belge D'Ophtalmologie|June 8, 2007
Iatrogenic ocular vascular occlusions: case reportsM van Lint, C De Cock, Ph Kestelyn, et al.
Orbit (Amsterdam, Netherlands)|May 3, 2014
Subconjunctival epidermoid cysts in Gorlin-Goltz syndromeS De Craene, A Batteauw, M Van Lint, et al.
Journal of Clinical Immunology|July 1, 1997
The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipidsW M Vuist, I N Van Schaik, M Van Lint, et al.
Journal of Neuroimmunology|September 1, 1990
On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathyP A van Doorn, F Rossi, A Brand, et al.
Journal of Lipid Research|March 15, 2002
Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disordersS Ferdinandusse, H Rusch, A E M van Lint, et al.
Immunological Reviews|August 1, 1989
Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: spontaneous and therapeuticI Lundkvist, P A van Doorn, M Vermeulen, et al.
Bone Marrow Transplantation|June 1, 1996
Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late EffectsA Tichelli, T Duell, M Weiss, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 9, 2019
Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significanceF H M van Lint, O R F Mook, M Alders, et al.
Molecular Genetics and Metabolism|July 12, 2003
Analysis of very long-chain fatty acids using electrospray ionization mass spectrometryFredoen Valianpour, Jacqueline J M Selhorst, Lia E M van Lint, et al.
Pageof 3